Piekos Brian
Insider CIK 1815308 · KALV Chief Financial Officer · ELTX Chief Financial Officer · GMTX Chief Financial Officer · AMAG Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 93,750 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 100,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 55,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer | 2026-06-11 | 2026-06-11 | 21,661 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-22 | 2026-05-26 | 1,489 | $26.78 | $39.9K | 21,661 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-21 | 2026-05-26 | 5,000 | — | $0 | 55,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-21 | 2026-05-26 | 5,000 | — | $0 | 23,150 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-04-17 | 2026-04-20 | 1,862 | $20.22 | $37.6K | 18,150 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-04-16 | 2026-04-20 | 6,250 | — | $0 | 93,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-04-16 | 2026-04-20 | 6,250 | — | $0 | 20,012 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-23 | 2026-02-24 | 1,767 | $15.57 | $27.5K | 13,762 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-21 | 2026-02-24 | 5,000 | — | $0 | 60,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-21 | 2026-02-24 | 5,000 | — | $0 | 15,529 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2026-01-16 | 2026-01-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-24 | 2025-11-26 | 4,471 | $13.45 | $60.1K | 10,529 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-21 | 2025-11-26 | 15,000 | — | $0 | 65,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-21 | 2025-11-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-02-21 | 2025-02-25 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-09-09 | 2024-09-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 43,225 | — | $0 | 43,225 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 75,484 | — | $0 | 75,484 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award | 2022-05-31 | 2022-06-02 | 9,960 | $1.09 | $10.9K | 17,615 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2022-01-13 | 2022-01-14 | 280,876 | — | $0 | 280,876 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-10-18 | 2021-10-20 | 90,720 | — | $0 | 90,720 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | P Buy | 2021-05-14 | 2021-05-18 | 7,655 | $9.46 | $72.4K | 7,655 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-04-12 | 2021-04-14 | 377,734 | — | $0 | 377,734 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 9,500 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer | 2020-11-16 | 2020-11-17 | 31,538 | — | $0 | 0 | SEC↗ |